{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:57:05Z","timestamp":1790686625556,"version":"4.1.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T00:00:00Z","timestamp":1376524800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0070939","type":"journal-article","created":{"date-parts":[[2013,8,16]],"date-time":"2013-08-16T04:23:59Z","timestamp":1376627039000},"page":"e70939","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":61,"title":["Imbalance between HAT and HDAC Activities in the PBMCs of Patients with Ankylosing Spondylitis or Rheumatoid Arthritis and Influence of HDAC Inhibitors on TNF Alpha Production"],"prefix":"10.1371","volume":"8","author":[{"given":"Eric","family":"Toussirot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasim","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashif Aziz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Tissot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Jeudy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Baud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wendling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Herbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,8,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jbspin.2010.03.009","article-title":"Histone deacetylase inhibitors: new treatment options for inflammatory joint disease?","volume":"77","author":"E Toussirot","year":"2010","journal-title":"Joint Bone Spine"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1002\/art.22948","article-title":"Epigenetics in inflammatory rheumatic diseases","volume":"56","author":"LC Huber","year":"2007","journal-title":"Arthritis Rheum"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/ar2500","article-title":"Epigenetic modifications in rheumatoid arthritis","volume":"10","author":"S Strietholt","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/ar2489","article-title":"Targeting histone deacetylase activity in rheumatoid arthritis and asthma as prototypes of inflammatory disease: should we keep our HATs on?","volume":"10","author":"AM Grabiec","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1359-6446(04)03309-4","article-title":"Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases?","volume":"10","author":"F Blanchard","year":"2005","journal-title":"Drug Discov Today"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1517\/13543784.13.1.21","article-title":"Histone deacetylase inhibitors in clinical development","volume":"13","author":"RR Rosato","year":"2004","journal-title":"Expert Opin Investig Drugs"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1615\/CritRevImmunol.v31.i3.40","article-title":"Function of histone deacetylase inhibitors in inflammation","volume":"31","author":"AM Grabiec","year":"2011","journal-title":"Crit Rev Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"7784","DOI":"10.4049\/jimmunol.0803800","article-title":"Bcl-3-regulated transcription from major immediate-early promoter of human cytomegalovirus in monocyte-derived macrophages","volume":"182","author":"KA Khan","year":"2009","journal-title":"J Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1074\/jbc.M209622200","article-title":"Exogenous Nef protein activates NF-kappaB, AP-1, and c-Jun N-terminal kinase and stimulates HIV transcription in promonocytic cells","volume":"278","author":"A Varin","year":"2003","journal-title":"Role Aids Pathog J Biol Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e16795","DOI":"10.1371\/journal.pone.0016795","article-title":"Role of HDAC3 on p53 expression and apoptosis in T cells of patients with multiple sclerosis","volume":"6","author":"F Zhang","year":"2011","journal-title":"PLOS ONE"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e6093","DOI":"10.1371\/journal.pone.0006093","article-title":"Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection","volume":"4","author":"S Reuse","year":"2009","journal-title":"PLOS ONE"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.4049\/jimmunol.162.7.4045","article-title":"Similarities and differences between human and murine TNF promoters in their response to lipopolysaccharide","volume":"162","author":"DV Kuprash","year":"1999","journal-title":"J Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1128\/JVI.72.1.660-670.1998","article-title":"Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes","volume":"72","author":"G Herbein","year":"1998","journal-title":"J Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13148-010-0002-6","article-title":"Histone deacetylase inhibitors: a new and promising drug class for the treatment of arthritis?","volume":"1","author":"E Toussirot","year":"2010","journal-title":"Clin Epigenetics"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/art.33382","article-title":"Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients","volume":"64","author":"J Gillespie","year":"2012","journal-title":"Arthritis Rheum"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/art.22512","article-title":"Histone deacetylase\/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients","volume":"56","author":"LC Huber","year":"2007","journal-title":"Arthritis Rheum"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"R133","DOI":"10.1186\/ar3071","article-title":"Increased activity and expression of histone deacetylase 1 in relation to tumor necrosis factor-alpha in synovial tissue of rheumatoid arthritis","volume":"12","author":"T Kawabata","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.3899\/jrheum.081115","article-title":"Expression and function of histone deacetylases in rheumatoid arthritis synovial fibroblasts","volume":"36","author":"M Horiuchi","year":"2009","journal-title":"J Rheumatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1128\/MCB.21.20.7065-7077.2001","article-title":"The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression","volume":"21","author":"BP Ashburner","year":"2001","journal-title":"Mol Cell Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.4161\/cc.22074","article-title":"Sirt1: def-eating senescence?","volume":"11","author":"S Fusco","year":"2012","journal-title":"Cell Cycle"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/art.33423","article-title":"Treatment of arthritis by macrophage depletion and immunomodulation: testing an apoptosis-mediated therapy in a humanized death receptor mouse model","volume":"64","author":"J Li","year":"2012","journal-title":"Arthritis Rheum"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/sj.bjp.0707165","article-title":"Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents","volume":"150","author":"HS Lin","year":"2007","journal-title":"Br J Pharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.joca.2007.10.014","article-title":"Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model","volume":"16","author":"Y Nasu","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2119\/molmed.2011.00030","article-title":"HDAC inhibition in rheumatoid arthritis and juvenile idiopathic arthritis","volume":"17","author":"J Vojinovic","year":"2011","journal-title":"Mol Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.4049\/jimmunol.176.8.5015","article-title":"Histone hyperacetylation is associated with amelioration of experimental colitis in mice","volume":"176","author":"R Glauben","year":"2006","journal-title":"J Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.4049\/jimmunol.0901467","article-title":"Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue","volume":"184","author":"AM Grabiec","year":"2010","journal-title":"J Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2119\/2006-00005.Dinarello","article-title":"The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo","volume":"11","author":"F Leoni","year":"2005","journal-title":"Mol Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1136\/ard.2010.148957","article-title":"SIRT1 overexpression in the rheumatoid arthritis synovium contributes to pro-inflammatory cytokine production and apoptosis resistance","volume":"70","author":"F Niederer","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1189\/jlb.0509363","article-title":"Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS","volume":"87","author":"MA Halili","year":"2010","journal-title":"J Leukoc Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1182\/blood-2010-05-284711","article-title":"Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection","volume":"117","author":"T Roger","year":"2011","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/infdis\/jir553","article-title":"Histone deacetylase inhibitors impair antibacterial defenses of macrophages","volume":"204","author":"M Mombelli","year":"2011","journal-title":"J Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1073\/pnas.052702999","article-title":"The anti-tumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits anti-inflammatory properties via suppression of cytokines","volume":"99","author":"F Leoni","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"G1047","DOI":"10.1152\/ajpgi.00016.2009","article-title":"Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNFalpha production in cultured macrophage cell lines","volume":"296","author":"Z Shen","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.4049\/jimmunol.173.6.3979","article-title":"Histone deacetylase 3, a class I histone deacetylase, suppresses MAPK11-mediated activating transcription factor-2 activation and represses TNF gene expression","volume":"173","author":"U Mahlknecht","year":"2004","journal-title":"J Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/art.30238","article-title":"Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis","volume":"63","author":"J Vojinovic","year":"2011","journal-title":"Arthritis Rheum"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0070939","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T21:55:44Z","timestamp":1688421344000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0070939"}},"subtitle":[],"editor":[{"given":"Pierre","family":"Bobe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,15]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0070939","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,15]]}}}